ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

NCI To Fund Approximately 850 Competing Grants In Fiscal 1986 Under Latest Budget Projections

February 28, 1986

Flexibility OK In Paying Grants If Justified, Upton Affirms

September 1, 1978

Disease Oriented Programs Must Be Coordinated: Rabson

October 15, 1976

Nominations Sought For Women’s Health Achievement AwardsFor Medical Devices

February 7, 1997

SBRT Delivers Higher Overall Survival Rates Compared to Conventional Radiation Therapy

November 30, 2012

GAO Report On NCI Cancer Control Contracts (Continued)

August 1, 1980